Table 3.
Cell subset | Stem cell graft Concentration, 109/L median (IQR) |
Correlation to pre-G-CSF concentrations, Rho/p-value |
Fold increase to pre-G-CSF concentrations | Correlation to post-G-CSF concentrations, Rho/p-value |
Fold increase to post-G-CSF concentrations |
---|---|---|---|---|---|
CD3 | 42 (30-59) | 0.41/0.03 | 28 | 0.43/0.02 | 14 |
CD4 | 26 (20-26) | 0.26/0.15 | 29 | 0.42/0.02 | 14 |
CD8 | 15 (9.4-22) | 0.53/0.003 | 35 | 0.50/0.008 | 15 |
TCR γδ | 0.98 (0.43-1.1) | 0.71/<0.001 | 38 | 0.62/0.001 | 16 |
Vδ1 | 0.23 (0.11-0.39) | 0.65/<0.001 | 29 | 0.60/0.001 | 15 |
Vδ2 | 0.34 (0.18-0.62) | 0.57/0.001 | 18 | 0.73/<0.001 | 10 |
NonVδ1-nonVδ2 | 0.08 (0.04-0.11) | 0.69/<0.001 | 44 | 0.82/<0.001 | 16 |
Naïve TCR γδ | 0.04 (0.02-0.07) | 0.78/<0.001 | 36 | 0.73/<0.001 | 15 |
Central memory TCR γδ | 0.09 (0.02-0.14) | 0.79/<0.001 | 30 | 0.72/<0.001 | 18 |
Effector memory TCR γδ | 0.25 (0.15-0.41) | 0.59/0.001 | 18 | 0.58/0.002 | 11 |
TEMRA γδ | 0.37 (0.22-0.58) | 0.71/<0.001 | 26 | 0.65/<0.001 | 13 |
Naive CD4 | 12 (8.9-19) | 0.41/0.02 | 39 | 0.67/<0.001 | 14 |
Central memory CD4 | 9.8 (8.2-15) | 0.49/0.007 | 30 | 0.43/0.02 | 15 |
Effector memory CD4 | 3.2 (1.9-4.8) | 0.41/0.02 | 26 | 0.37/0.05 | 14 |
TEMRA CD4 | 0.13 (0.09-0.79) | 0.62/0.001 | 37 | 0.67<0.001 | 8 |
Naive CD8 | 4.6 (2.9-6.0) | 0.63/<0.001 | 56 | 0.55/0.003 | 17 |
Central memory CD8 | 1.1 (0.9-2.0) | 0.41/0.02 | 23 | 0.45/0.02 | 17 |
Effector memory CD8 | 3.5 (2.4-6.1) | 0.53/0.003 | 25 | 0.67/<0.001 | 15 |
TEMRA CD8 | 4.3 (1.1-6.5) | 0.69/<0.001 | 37 | 0.40/0.03 | 12 |
NK cells (CD16/56) | 4.6 (3.1-7.7) | 0.36/0.05 | 17 | 0.37/0.05 | 10 |
CD56dim | 4.3 (2.9-7.3) | 0.33/0.07 | 16 | 0.38/0.04 | 10 |
CD56bright | 0.33 (0.21-0.46) | 0.46/0.01 | 22 | 0.53/0.004 | 11 |
Rho correlation coefficient and p-values from Kendall’s tau-b test for correlation to peripheral blood concentration before and after G-CSF. Median fold increase.